Carter Bankshares, Inc.
NASDAQ:CAREBanks - Regional
-$0.20 today
- Market cap
- $635.59M
- Beta
- 0.55
- P/E (TTM)
- 6.2
- EPS (TTM)
- $4.95
- Dividend yield
- 0.33%
Volume 0.19M
Average 0.32M
CARE Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Carter Bankshares, Inc.NASDAQ: CARE
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue turns negative
Q1 FY2026 cost of revenue was -$10.88M, compared with $23.73M a year earlier. Trailing-twelve-month cost of revenue was $62.96M. Over 3 fiscal years it compounded at +61.5% a year.
Context
- Cost of revenue amounted to 38.3% of revenue in FY2025, down 4.3 pp from a year earlier.
- Cost of revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly cost of revenue holds near -$10.88M or moves back toward the trailing-twelve-month quarterly average of $15.74M.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 97.57M USD
- Year-over-year change
- -4.6%
- 4-year CAGR
- +40.8%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 97.57M | -4.6% |
| FY2024 | 2024-12-31 | 102.23M | +27.0% |
| FY2023 | 2023-12-31 | 80.51M | +247.3% |
| FY2022 | 2022-12-31 | 23.18M | -6.5% |
| FY2021 | 2021-12-31 | 24.8M | — |
Cost of Revenue vs competitors
How CARE compares with its peers on the latest reported figures
- CARE's LTM Mar 2026 cost of revenue of $62.96M is the 6th highest of the 11 companies compared; the peer median is $68.6M.
- Its year-over-year change of -37.3% is the lowest of 11, against a peer median of -12.8%.
- Cost of revenue amounts to 19.7% of revenue for CARE, versus a peer median of 37.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $579.74M | +31.5% | +87.3% | 94.0% | |
| LTM Mar 2026 | $112.67M | +8.9% | +83.9% | 45.4% | |
| LTM Mar 2026 | $96.18M | -24.5% | +51.9% | 45.4% | |
| LTM Mar 2026 | $83.77M | -28.8% | +61.1% | 40.7% | |
| LTM Mar 2026 | $79.31M | +4.9% | +65.5% | 32.7% | |
| LTM Mar 2026 | $62.96M | -37.3% | +61.5% | 19.7% | |
| LTM Mar 2026 | $57.9M | +1.6% | +72.6% | 30.7% | |
| LTM Mar 2026 | $55.1M | -4.0% | +46.0% | 44.9% | |
| LTM Mar 2026 | $50.44M | -29.7% | +8.7% | 35.0% | |
| LTM Mar 2026 | $27.76M | -21.6% | +98.7% | 32.2% | |
| LTM Mar 2026 | $17.67M | -23.4% | +29.8% | 10.1% | |
| Peer median (excluding CARE) | $68.6M | -12.8% | +63.3% | 37.9% | |
Competitors are the stored peer set for CARE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 156.38M | 179.15M | 211.82M | 239.67M | 254.63M |
| Cost of Revenue | 24.8M | 23.18M | 80.51M | 102.23M | 97.57M |
| Gross Profit | 131.58M | 155.97M | 131.31M | 137.45M | 157.06M |
| Gross Margin | 84.1% | 87.1% | 62.0% | 57.3% | 61.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 57.27M | 55.85M | 62.45M | 66.65M | 75.36M |
| Operating Expenses | 95.89M | 94.25M | 102.59M | 106.58M | 117.05M |
| Depreciation & Amortization | 6.23M | 6.06M | 6.25M | 7.06M | 7.86M |
| EBITDA | 41.93M | 67.78M | 34.97M | 37.92M | 47.86M |
| EBITDA Margin | 26.8% | 37.8% | 16.5% | 15.8% | 18.8% |
| Operating Income | 35.7M | 61.72M | 28.72M | 30.87M | 40M |
| Operating Margin | 22.8% | 34.4% | 13.6% | 12.9% | 15.7% |
| Interest Income | 133.78M | 160.03M | 194.96M | 220.72M | 232.22M |
| Interest Expense | 22.71M | 20.25M | 74.11M | 107.27M | 101.4M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 35.7M | 61.72M | 28.72M | 30.87M | 40M |
| Pre-Tax Margin | 22.8% | 34.4% | 13.6% | 12.9% | 15.7% |
| Income Tax Expense | 4.11M | 11.6M | 5.34M | 6.35M | 8.64M |
| Net Income | 31.59M | 50.12M | 23.38M | 24.52M | 31.36M |
| Net Margin | 20.2% | 28.0% | 11.0% | 10.2% | 12.3% |
| EPS (Basic) | 1.20 | 2.03 | 1.00 | 1.06 | 1.40 |
| EPS (Diluted) | 1.20 | 2.03 | 1.00 | 1.06 | 1.40 |
| Weighted Avg Shares | 26.34M | 24.6M | 23.24M | 23.24M | 22.46M |
| Weighted Avg Shares (Diluted) | 26.34M | 24.6M | 23.24M | 23.24M | 22.46M |
Carter Bankshares, Inc.
NASDAQ:CARE
Intrinsic Alpha fair value
Locked
Current Price
$28.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.